Managing diseases such as lymphedema and heart failure is a huge challenge for patients, clinicians and healthcare systems. Using objective tools that make earlier detection and ongoing monitoring easier, you have an opportunity to provide simpler, more timely interventions that can improve quality of life and lower healthcare costs.
SOZO, the world’s most advanced, noninvasive bioimpedance spectroscopy (BIS) device, incorporates L-Dex® technology to aid in the assessment of secondary lymphedema and delivers a precise snapshot of fluid status and tissue composition in less than 30 seconds.
ImpediMed devices offer clinicians a fast, easy, noninvasive and low-cost way to measure fluid status and tissue composition. The data delivered by our technology aids in the early detection of secondary lymphedema and provides fluid status for patients living with heart failure.
ImpediMed’s use of BIS has been studied extensively for lymphedema, heart failure and body composition in a wide variety of disease states and for veterinary research applications.